β2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade

Journal of Physiology

Volumn 588, Issue 14, 2010, Pages 2669-2678

  Hesse, Christiane ^a   Schroeder, Darrell R ^a   Nicholson, Wayne T ^a   Hart, Emma C ^a   Curry, Timothy B ^a   Penheiter, Alan R ^b   Turner, Stephen T ^a   Joyner, Michael J ^a   Eisenach, John H ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLENE; ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLUTAMIC ACID; GLUTAMINE; GLYCINE; NOVAPLUS; PHENYLEPHRINE; TERBUTALINE; TRIMETAPHAN; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GANGLION BLOCKING AGENT;

ADULT; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; BLOOD PRESSURE; BRACHIAL ARTERY; BREATHING; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MEGADOSE; EX VIVO STUDY; FEMALE; GANGLION BLOCK; GENETIC VARIABILITY; HAPLOTYPE; HEART OUTPUT; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR BINDING; RECEPTOR DENSITY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; ADOLESCENT; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HEART RATE; NERVE BLOCK; PHYSIOLOGY; VASCULAR RESISTANCE; ADRB2 GENE; BINDING AFFINITY; DNA CONFORMATION; GENE;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AUTONOMIC NERVE BLOCK; BAROREFLEX; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIAC OUTPUT; FEMALE; GANGLIONIC BLOCKERS; HEART RATE; HUMANS; MALE; PHENYLEPHRINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; TERBUTALINE; TRIMETHAPHAN; VASCULAR RESISTANCE; VASODILATION; YOUNG ADULT;

EID: 77954712962     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.190058     Document Type: Article

References (30)

1. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000, 101:2877-2882.
2. Bruck H, Leineweber K, Park J, Weber M, Heusch G, Philipp T, Brodde OE. Human β2-adrenergic receptor gene haplotypes and venodilation in vivo. Clin Pharmacol Ther 2005, 78:232-238.
3. Cockcroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, Noon JP. β2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000, 36:371-375.
4. Dishy V, Sofowora GG, Imamura H, Nishimi Y, Xie HG, Wood AJ, Stein CM. Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 2003, 21:153-157.
5. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ. The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001, 345:1030-1035.
6. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB. Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000, 97:10483-10488.
7. Eisenach JH, Barnes SA, Pike TL, Sokolnicki LA, Masuki S, Dietz NM, Rehfeldt KH, Turner ST, Joyner MJ. The Arg16/Gly β2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise. J Appl Physiol 2005, 99:1776-1781.
8. Eisenach JH, McGuire AM, Schwingler RM, Turner ST, Joyner MJ. The Arg16/Gly β2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol Genomics 2004, 16:323-328.
9. Eisenach JH, Schroeder DR, Pike TL, Johnson CP, Schrage WG, Snyder EM, Johnson BD, Garovic VD, Turner ST, Joyner MJ. Dietary sodium restriction and β2-adrenergic receptor polymorphism modulate cardiovascular function in humans. J Physiol 2006, 574:955-965.
10. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST. β2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003, 546:583-589.
11. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F. β2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999, 33:1425-1430.
12. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994, 33:9414-9419.
13. Heckbert SR, Hindorff LA, Edwards KL, Psaty BM, Lumley T, Siscovick DS, Tang Z, Durda JP, Kronmal RA, Tracy RP. β2-Adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003, 107:2021-2024.
14. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB. β2-Adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000, 139:537-542.
15. Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B. β2-Adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. Clin Pharmacol Ther 2006, 80:633-645.
16. Johnson BD, Beck KC, Proctor DN, Miller J, Dietz NM, Joyner MJ. Cardiac output during exercise by the open circuit acetylene washin method: comparison with direct Fick. J Appl Physiol 2000, 88:1650-1658.
17. Jordan J, Tank J, Shannon JR, Diedrich A, Lipp A, Schroder C, Arnold G, Sharma AM, Biaggioni I, Robertson D, Luft FC. Baroreflex buffering and susceptibility to vasoactive drugs. Circulation 2002, 105:1459-1464.
18. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D. β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 2003, 13:379-382.
19. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. β2-Adrenergic receptor genotype and survival among patients receiving β-blocker therapy after an acute coronary syndrome. JAMA 2005, 294:1526-1533.
20. Lee DK, Bates CE, Lipworth BJ. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous β2-adrenoceptor haplotypes at positions 16 and 27. Br J Clin Pharmacol 2004, 57:100-104.
21. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJ. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin Pharmacol Ther 1990, 48:87-95.
22. Qing F, Rahman SU, Hayes MJ, Rhodes CG, Ind PW, Jones T, Hughes JM. Effect of long-term β2-agonist dosing on human cardiac β-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte β-receptors. J Nucl Cardiol 1997, 4:532-538.
23. Sehnert AJ, Daniels SE, Elashoff M, Wingrove JA, Burrow CR, Horne B, Muhlestein JB, Donahue M, Liggett SB, Anderson JL, Kraus WE. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. J Am Coll Cardiol 2008, 52:644-651.
24. Shannon JR, Jordan J, Black BK, Costa F, Robertson D. Uncoupling of the baroreflex by NN-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension 1998, 32:101-107.
25. Shin J, Lobmeyer MT, Gong Y, Zineh I, Langaee TY, Yarandi H, Schofield RS, Aranda JM, Hill JA, Pauly DF, Johnson JA. Relation of β2-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol 2007, 99:250-255.
26. Snyder EM, Beck KC, Dietz NM, Eisenach JH, Joyner MJ, Turner ST, Johnson BD. Arg16Gly polymorphism of the β2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol 2006a, 571:121-130.
27. Snyder EM, Hulsebus ML, Turner ST, Joyner MJ, Johnson BD. Genotype related differences in β2 adrenergic receptor density and cardiac function. Med Sci Sports Exerc 2006b, 38:882-886.
28. Sotoodehnia N, Siscovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA, Lemaitre RN, Rea TD, Durda JP, Chang JM, Lumley TS, Kuller LH, Burke GL, Heckbert SR. β2-Adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 2006, 113:1842-1848.
29. Tang W, Devereux RB, Kitzman DW, Province MA, Leppert M, Oberman A, Hopkins PN, Arnett DK. The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function. Am J Hypertens 2003, 16:945-951.
30. Trombetta IC, Batalha LT, Rondon MU, Laterza MC, Frazzatto E, Alves MJ, Santos AC, Brum PC, Barretto AC, Halpern A, Villares SM, Negrao CE. Gly16 + Glu27 β2-adrenoceptor polymorphisms cause increased forearm blood flow responses to mental stress and handgrip in humans. J Appl Physiol 2005, 98:787-794.